Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | +1.90% | -1.29% | +16.41% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.41% | 6.6B | |
+27.07% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.54% | 26.09B | |
-22.42% | 18.71B | |
+7.98% | 13.26B | |
+32.05% | 12.32B | |
+0.16% | 11.99B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11